This is a StreetInsider.com Premium Only Page

OPKO Health (OPK) – Company Press Releases

Mar 28, 2024 08:00 AM Labcorp Announces Acquisition of Select Assets of BioReference Health's Diagnostics Business

Mar 20, 2024 08:00 AM Entera Bio Announces Robust Pharmacokinetic Data for First-in-Class Oral GLP-2 Peptide Tablet Treatment for Patients with Short Bowel Syndrome

Mar 5, 2024 08:52 AM AIDS Clinical Trial Group Presents Results from Phase 1 Study of ModeX Trispecific Antibody for the Treatment and Prevention of HIV

Feb 28, 2024 09:31 AM NextPlat Opens OPKO Health-Branded Storefront on Alibaba's Tmall Global Platform in China on March 1st

Feb 27, 2024 04:05 PM OPKO Health Reports Fourth Quarter 2023 Business Highlights and Financial Results

Feb 22, 2024 04:05 PM OPKO Health to Report Fourth Quarter 2023 Financial Results on February 27, 2024

Feb 5, 2024 08:09 AM NextPlat Receives Initial Approvals to Launch OPKO Health-Branded Storefront on Alibaba's Tmall Global Platform in China

Jan 9, 2024 04:05 PM OPKO Health Announces Closing of Private Offering of $230 Million Convertible Senior Notes Due 2029 including Full Exercise of Initial Purchaser’s Option to Purchase Additional Notes

Jan 8, 2024 08:00 AM OPKO Health to Present at the 42nd Annual J.P. Morgan Healthcare Conference

Jan 4, 2024 11:31 PM OPKO Health Announces Pricing of Private Offering of $200 Million Convertible Senior Notes Due 2029

Jan 3, 2024 05:05 PM OPKO Health Announces Private Offering of Convertible Senior Notes Due 2029

Nov 28, 2023 07:00 AM BioReference Health and Prognos Health Collaborate to Advance Precision Medicine and Testing

Nov 7, 2023 06:45 AM BioReference® Signs On as the First Laboratory to Use MSK-ACCESS® Powered with SOPHiA DDM™

Nov 6, 2023 04:05 PM OPKO Health Reports Third Quarter 2023 Business Highlights and Financial Results

Nov 2, 2023 10:00 AM New Clinical Data on OPKO Health’s RAYALDEE® (ER Calcifediol) Presented at Kidney Week 2023

Oct 31, 2023 08:00 AM OPKO Health to Report Third Quarter 2023 Financial Results on November 6, 2023

Oct 25, 2023 04:25 PM OPKO Health to Present New Clinical Data on Rayaldee (ER Calcifediol) at Kidney Week 2023

Oct 12, 2023 10:50 AM NextPlat's Florida E-Commerce Development Program to Launch the Online Sales of OPKO Healthcare Products in China on Alibaba's Tmall Global

Oct 12, 2023 10:50 AM NextPlat's Florida E-Commerce Development Program to Launch the Online Sales of OPKO Healthcare Products in China on Alibaba's Tmall Global

Sep 28, 2023 04:08 PM ModeX Therapeutics Secures BARDA Contract to Develop Novel Multispecific Antibodies Against Viral Infectious Disease Threats

Sep 12, 2023 08:30 AM Entera Bio Announces Collaboration with OPKO Biologics to Develop Oral Peptide Tablet Formulations for Obesity and Intestinal Malabsorption Syndromes

Aug 3, 2023 04:05 PM OPKO Health Reports Second Quarter 2023 Business Highlights and Financial Results

Jul 25, 2023 04:05 PM OPKO Health to Report Second Quarter 2023 Financial Results on August 3, 2023

Jun 28, 2023 06:45 AM FDA Approves Pfizer’s NGENLA™, a Long-Acting Once-Weekly Treatment for Pediatric Growth Hormone Deficiency

May 3, 2023 04:05 PM OPKO Health Reports First Quarter 2023 Business Highlights and Financial Results

Apr 25, 2023 04:05 PM OPKO Health to Report First Quarter 2023 Financial Results on May 3, 2023

Mar 9, 2023 08:00 AM OPKO Health to Hold Virtual R&D Day on March 20, 2023

Mar 8, 2023 08:00 AM OPKO Health’s ModeX Therapeutics Enters into Exclusive Worldwide License and Collaboration Agreement with Merck to Develop Epstein-Barr Virus Vaccine Candidate

Feb 23, 2023 04:05 PM OPKO Health Reports Fourth Quarter 2022 Business Highlights and Financial Results

Feb 16, 2023 11:41 AM OPKO Health to Report Fourth Quarter 2022 Financial Results on February 23, 2023

Feb 9, 2023 07:05 AM BioReference Now Offers the Only FDA-Approved Dual-Stain Triage Test to Enhance Cervical Cancer Screenings

Jan 3, 2023 08:00 AM OPKO Health to Present at the 41st Annual J.P. Morgan Healthcare Conference

Nov 8, 2022 04:05 PM OPKO Health Reports Third Quarter 2022 Business Highlights and Financial Results

Nov 1, 2022 08:00 AM OPKO Health to Report Third Quarter 2022 Financial Results on November 8, 2022

Sep 15, 2022 04:05 PM Jon Cohen and Michael Hansen Join Talkspace’s Board of Directors

Sep 15, 2022 04:05 PM Jon Cohen and Michael Hansen Join Talkspace’s Board of Directors

Aug 16, 2022 04:29 PM OPKO Health Announces Leadership Changes for BioReference Laboratories

Aug 4, 2022 04:05 PM OPKO Health Reports 2022 Second Quarter Business Highlights and Financial Results

Jul 25, 2022 04:05 PM OPKO Health to Report Second Quarter 2022 Financial Results on August 4, 2022

Jun 2, 2022 08:00 AM OPKO Health to Present at the 2022 Jefferies Healthcare Conference

May 9, 2022 04:05 PM OPKO Health Reports 2022 First Quarter Business Highlights and Financial Results

May 9, 2022 09:23 AM OPKO Health Acquires ModeX Therapeutics, Gains Proprietary Immunotherapy Technology with a Focus on Oncology and Infectious Diseases

May 5, 2022 04:05 PM OPKO Health to Report First Quarter 2022 Financial Results on May 9, 2022

May 2, 2022 07:45 AM Sema4 Announces the Completion of the GeneDx Acquisition and a Streamlined Leadership Structure to Accelerate Growth of its Diagnostic and Clinical Data Platforms

Mar 16, 2022 07:30 AM GeneDx Announces Discovery of 200 New and Expanded Genetic Conditions

Mar 1, 2022 06:00 AM Saol Therapeutics and GeneDx, Inc. Collaborate to Detect Patients with Rare Mitochondrial Disease

Feb 24, 2022 04:05 PM OPKO Health Reports 2021 Fourth Quarter Business Highlights and Financial Results

Feb 17, 2022 08:00 AM OPKO Health to Report Fourth Quarter 2021 Financial Results on February 24, 2022

Feb 15, 2022 11:08 AM Pfizer and OPKO’s Once-Weekly NGENLA™ (somatrogon) Injection Receives Marketing Authorization in European Union for Treatment of Pediatric Growth Hormone Deficiency

Feb 3, 2022 08:30 AM RAYALDEE® Launched in Germany by OPKO Health’s Licensee, VFMCRP